메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Debadrita Ray (Department of Hematology Postgraduate Institute of Medical Education and Research Chandigarh India) Narender Kumar (Department of Hematology Postgraduate Institute of Medical Education and Research Chandigarh India) Chander Hans (Department of Hematology Postgraduate Institute of Medical Education and Research Chandigarh India) Anita Kler (Department of Hematology Postgraduate Institute of Medical Education and Research Chandigarh India) Richa Jain (Department of Paediatrics Postgraduate Institute of Medical Education and Research Chandigarh India) Deepak Bansal (Department of Paediatrics Postgraduate Institute of Medical Education and Research Chandigarh India) Amita Trehan (Department of Paediatrics Postgraduate Institute of Medical Education and Research Chandigarh India) Arihant Jain (Department of Internal Medicine Postgraduate Institute of Medical Education and Research Chandigarh India) Pankaj Malhotra (Department of Internal Medicine Postgraduate Institute of Medical Education and Research Chandigarh India) Jasmina Ahluwalia (Department of Hematology Postgraduate Institute of Medical Education and Research Chandigarh India)
저널정보
대한혈액학회 Blood Research Blood Research Vol.58 No.1
발행연도
2023.3
수록면
61 - 70 (10page)
DOI
10.5045/br.2023.2022197

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background The clinical phenotype of hemophilia A (HA) does not always correlate with severity. Similarly, the presence of inhibitors does not necessarily increase the risk of bleeding. This paradox between clinical and laboratory findings may be partially attributed to non-modifiable factors, such as blood group, which is known to influence FVIII levels in healthy individuals. Our aim was to assess the effect of ABO blood group antigens on FVIII levels across the severity spectrum of HA and risk of inhibitor development. Methods Data of consecutive patients with HA who visited the coagulation unit of a northern Indian tertiary care hospital between 2010‒2021 were reviewed. Patients with missing blood group data, transfusion histories, or baseline FVIII levels were excluded. Results Mild, moderate, and severe HA was present in 41 (6.9%), 72 (12.2%), and 479 (80.9%) patients, respectively. There were no differences in the FVIII levels among the various blood groups across the HA severity spectrum. Inhibitors were administered to 35 patients (5.9%). In the multivariate analysis, blood group A was an independent risk factor for the development of inhibitors (adjusted odds ratio 2.70, P =0.04) after adjusting for age at onset of bleeding, FVIII transfusion, age at first FVIII transfusion, and severity of HA. Conclusion Unlike what is observed in healthy individuals, blood group did not influence residual FVIII levels across the severity spectrum of HA. Patients in group A had a higher risk of developing inhibitors.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0